The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases

CONCLUSIONS: Across the reviewed disease areas, behavioral interventions and pharmacotherapies are shown to be critical components of clinical practice. Over the last 20 years, novel pharmaceutical innovations have been incorporated into clinical practice guideline recommendations; however, with varying speeds of adoption. Given the increasing pace of pharmacologic innovation, timely updates of clinical practice guidelines are critical to evolving the standard of care and practicing evidence-based medicine.PMID:38505696 | PMC:PMC10950408 | DOI:10.1155/2024/5877687

Source: Clinical Lung Cancer - March 20, 2024 Category: Cancer & Oncology Authors: Meaghan Roach Natalie Land Jennifer Hernandez Reina Rau Jacquelyn W Chou Stacey S Hickson Danielle F Rollmann J Ross Maclean Source Type: research